This list allows licensed compounding pharmacies to prepare medications using these substances under specific regulations
Your cells respond to GHK-Cu through specific receptors
Consecutive sections (5 m) were prepared and mounted on glass slides
In this experimental platform, the anti-gravity calf-muscle group (gastrocnemius (Gas), plantaris (Pla), and soleus (Sol) muscles) and shank muscles (tibialis anterior (TA) and extensor digitorum longus (EDL)) were collected from four experimental groups of 8-week-old C57BL/6J male mice: i) control (without any treatment), ii) 5-days suspension-disuse, iii) 3-days LASSS pre-administration (about 50 g in drinking water/g body weight/day) followed by 5-days suspension-disuse treatment without LASSS supplementation, and iv) 3-days GSSSG pre-administration followed by suspension-disuse treatment ( n = 3 mice per group)
April 15, 2026: In the updated 503A document, the FDA announced it is removing BPC-157 (both BPC-157 acetate and BPC-157 free base) from Category 2 and scheduling a PCAC meeting for July 23, 2026